<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Following <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo>, delayed <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> from <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> remains the most important cause of mortality and morbidity in patients with surgically secured <z:hpo ids='HP_0002617'>aneurysms</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Therapy with haemodilution, <z:hpo ids='HP_0000822'>hypertension</z:hpo> and volume expansion has been recommended to prevent and treat delayed <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> in these patients on the basis of uncontrolled clinical series (level of evidence III to V, grade C recommendation) </plain></SENT>
<SENT sid="2" pm="."><plain>Despite the lack of controlled studies, the maintenance of a cardiac index &gt; 3.5 L.min-1.m-2 and a systolic arterial pressure between 120 and 150 mmHg before clipping and 160 to 200 mmHg thereafter is recommended as a prophylactic or therapeutic measure for vasospasm </plain></SENT>
<SENT sid="3" pm="."><plain>Close monitoring of neurological and cardiorespiratory status is important to avoid neurologic and systemic complications </plain></SENT>
</text></document>